[Primary vitrectomy with intraocular antibiotic application in postoperative endophthalmitis].
OBJECTIVE
Pars plana vitrectomy with intravitreal antibiotic application is an established procedure for treating postoperative endophthalmitis. The presented study analyzes our own results with this treatment as well as the role of adjuvant systemic steroid treatment.


METHODS
We analyzed the data of 34 consecutive patients with postoperative endophthalmitis from January 2000 to March 2006. Thirty-two patients underwent vitrectomy and intravitreal application of antibiotics, and two patients received intravitreal antibiotics only. All patients received intravitreal dexamethasone and systemic antibiotics, and 12 patients received the systemic treatment with prednisolone. The effect of vitrectomy with respect to final visual acuity and the rate of postoperative complications were analyzed. The vitreous was microbiologically examined. Postoperative follow-up time ranged from 2 weeks to 24 months.


RESULTS
Endophthalmitis followed cataract surgery with intraocular lens implantation in 30 patients (89%) and followed pars plana vitrectomy in four patients (11%). Positive cultures were obtained in 19 (56%) patients. Visual acuity improved in 31 (91%) patients. At their final examinations, 27 (79%) patients had gained visual acuity of 0.05 or better.


CONCLUSIONS



CONCLUSIONS
Immediate vitrectomy in combination with intraocular antibiotics and steroid administration resulted in preservation of ambulatory vision in most of the patients. Systemic postoperative therapy with steroids seems to be associated with better final visual acuity.
Rehak
M
M
Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum AöR, Universität Leipzig, Liebigstrasse 10-14, 04103, Leipzig.
Blatz
R
R
Wiedemann
P
P
Meier
P
P
D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D003131:Combined Modality Therapy; D009877:Endophthalmitis / Q000209:etiology* / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013508:Ophthalmologic Surgical Procedures / Q000009:adverse effects*; D011182:Postoperative Care / Q000379:methods; D013256:Steroids / Q000008:administration & dosage*; D014821:Vitrectomy
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D013256:Steroids
Am J Ophthalmol. 2004 Jan;137(1):38-42
14700642
Retina. 1994;14(4):297-304
7817022
Retina. 2006 Jul-Aug;26(6 Suppl):S47-50
16832300
Ophthalmology. 2006 Aug;113(8):1472-3; author reply 1473.e1-2
16877090
Curr Opin Ophthalmol. 2006 Jun;17(3):286-91
16794443
Ophthalmologe. 2006 Jan;103(1):30-4
15915332
Am J Ophthalmol. 2005 Jun;139(6):1097-8
15953444
Ophthalmologe. 2006 Jun;103(6):484-92
16763865
Arch Ophthalmol. 2005 May;123(5):613-20
15883279
Ophthalmologe. 2002 Dec;99(12):922-6
12478378
Am J Ophthalmol. 1996 Jul;122(1):1-17
8659579
Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1200-5
16235062
J Fr Ophtalmol. 1993;16(8-9):446-52
8282952
Arch Ophthalmol. 1995 Dec;113(12):1479-96
7487614
Br J Ophthalmol. 1997 Nov;81(11):1006-15
9505828
Ophthalmologe. 2005 Sep;102(9):888-90
15480698
Klin Monbl Augenheilkd. 1997 Apr;210(4):175-91
9235391
Graefes Arch Clin Exp Ophthalmol. 2005 Dec;243(12):1197-9
16136321
Arch Ophthalmol. 2005 Mar;123(3):341-6
15767476
Eur J Ophthalmol. 2006 Mar-Apr;16(2):300-5
16703550
Ophthalmology. 2001 Feb;108(2):240-1
11158783
Retina. 2006 Jul-Aug;26(6 Suppl):S45-6
16832299
Br J Ophthalmol. 1999 Sep;83(9):1050-5
10460774
Am J Ophthalmol. 2005 Jun;139(6):983-7
15953426
Ophthalmologe. 2000 Jan;97(1):33-7
10663787
Ophthalmologe. 1997 Aug;94(8):552-6
9376692
Jpn J Ophthalmol. 2000 Jul-Aug;44(4):439-42
10974303
Curr Opin Ophthalmol. 2005 Feb;16(1):65-70
15650583
Ophthalmology. 1992 Mar;99(3):301-2
1565439
Ophthalmology. 2006 Apr;113(4):714
16581433
Eur J Med Res. 2005 Feb 28;10(2):71-5
15817426
Am J Ophthalmol. 1986 Mar 15;101(3):332-41
3485382